1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Mammalian Models of Parkinson's Disease-Reference-Cited by-同舟云学术

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Mammalian Models of Parkinson's Disease

Published:2008 Issue: Volume: Page:87-103
ISSN:
Container-title:Parkinson's Disease
language:
Short-container-title:

Author:

Schneider J.S.,Anderson D.W.,Decamp E.

Publisher

Elsevier

Reference99 articles.

1. Anderson, D. W., Schneider, J. S. (2006). Microglial activation and perpetuation of neurodegeneration in MPTP-treated mice are dependent upon toxin administration protocol, Society for Neuroscience, Vol. Program No. 75.4. Neuroscience Meeting Planner, Atlanta, GA.

2. Neuroprotective effects of pramipexole in young and aged MPTP-treated mice;Anderson;Brain Res,2001

3. Neuroprotection in Parkinson models varies with toxin administration protocol;Anderson;Eur J Neurosci,2006

4. Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys;Asselin;Neuroreport,1994

5. Cellular localization of enkephalin gene expression in MPTP-treated cynomologus monkeys;Augood;Mol Brain Res,1989

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Models of Neurodegenerative Diseases;Neurogenetics;2022-12-09

2. Modeling sleep alterations in Parkinson's disease: How close are we to valid translational animal models?;Sleep Medicine Reviews;2016-02

3. Development of preclinical diagnosis and preventive treatment of neurodegenerative diseases;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2015

4. Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency;Brain Research;2014-03

5. Modeling of presymptomatic and symptomatic stages of parkinsonism in mice;Neuroscience;2011-05